Oncology Morning Commute: Recognition of Actionable Biomarkers in Colorectal Cancer
Released Friday, 23rd December 2022
Good episode? Give it some love!
Oncology Morning Commute: Recognition of Actionable Biomarkers in Colorectal Cancer
Oncology Morning Commute: Recognition of Actionable Biomarkers in Colorectal Cancer
Friday, 23rd December 2022
Good episode? Give it some love!
Rate Episode
In this first podcast of our three-part series, our faculty discuss biomarkers for colorectal cancer including HER2. Are you aware of the current guideline recommendations for biomarker testing in colorectal cancer?
Visit http://www.MorningCommutePodcast.com/CRC1 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
Show More
Rate
Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Episode Tags
Do you host or manage this podcast?
Claim and edit this page to your liking.
,Claim and edit this page to your liking.
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us